Walgreens Boots Alliance sold the remaining shares of Option Care Health on Thursday for more than $330 million, marking the end of their stake in the company.
The drugstore chain will use the proceeds from the sale of 10.8 million shares of what was once known as Walgreens Infusion Services to reduce debt, the company said in a press release Thursday. Walgreens Boots has gradually sold Option Care stock. In March, the company sold 15.5 million shares of Option Care at $30.75 per share.
The transaction comes less than a month after Option Care announced plans to acquire Amedisys for $3.6 billion, although UnitedHealth Group’s Optum is also vying for the company.
Shares of Walgreens closed at $31.85 on the Nasdaq Stock Exchange on Thursday, down 2.5% from its opening price. The company’s shares opened at $31.78 on Friday.
